Sarfati E - Search Results

1

Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.

Koumakis E, Souberbielle JC, Payet J, Sarfati E, Borderie D, Kahan A, Cormier C. Koumakis E, et al. Among authors: sarfati e. Osteoporos Int. 2014 Jul;25(7):1963-8. doi: 10.1007/s00198-014-2689-2. Epub 2014 Mar 28. Osteoporos Int. 2014. PMID: 24676846

2

Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.

Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, Borderie D, Kahan A, Cormier C. Koumakis E, et al. Among authors: sarfati e. J Clin Endocrinol Metab. 2013 Aug;98(8):3213-20. doi: 10.1210/jc.2013-1518. Epub 2013 Jun 19. J Clin Endocrinol Metab. 2013. PMID: 23783096

3

Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy.

Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Boudou P, et al. Among authors: sarfati e. J Bone Miner Metab. 2009;27(2):240-6. doi: 10.1007/s00774-008-0033-7. Epub 2009 Jan 27. J Bone Miner Metab. 2009. PMID: 19172220

4

A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.

Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Boudou P, et al. Among authors: sarfati e. J Endocrinol Invest. 2006 Jun;29(6):511-5. doi: 10.1007/BF03344140. J Endocrinol Invest. 2006. PMID: 16840828

5

Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism.

Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Boudou P, et al. Among authors: sarfati e. Clin Chem. 2006 Apr;52(4):757-60. doi: 10.1373/clinchem.2005.060962. Epub 2006 Feb 23. Clin Chem. 2006. PMID: 16497941

6

Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism.

Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC. Boudou P, et al. Among authors: sarfati e. J Clin Endocrinol Metab. 2005 Dec;90(12):6370-2. doi: 10.1210/jc.2005-0715. Epub 2005 Sep 27. J Clin Endocrinol Metab. 2005. PMID: 16189258

7

Correction of severe secondary hyperparathyroidism in two dialysis patients: surgical removal versus percutaneous ethanol injection.

Page B, Zingraff J, Souberbielle JC, Coutris G, Sarfati E, Drüeke T, Moreau JF. Page B, et al. Among authors: sarfati e. Am J Kidney Dis. 1992 Apr;19(4):378-81. doi: 10.1016/s0272-6386(12)80458-6. Am J Kidney Dis. 1992. PMID: 1562029

8

The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects.

Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C. Souberbielle JC, et al. Among authors: sarfati e. J Clin Endocrinol Metab. 2003 Aug;88(8):3501-4. doi: 10.1210/jc.2003-030097. J Clin Endocrinol Metab. 2003. PMID: 12915625 Clinical Trial.

9

Acute primary hyperparathyroidism: experience of 59 cases.

Sarfati E, Desportes L, Gossot D, Dubost C. Sarfati E, et al. Br J Surg. 1989 Sep;76(9):979-81. doi: 10.1002/bjs.1800760937. Br J Surg. 1989. PMID: 2804604

10

Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate.

Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drüeke T, Bourdeau A. Roussanne MC, et al. Among authors: sarfati e. Eur J Clin Invest. 2001 Jul;31(7):610-6. doi: 10.1046/j.1365-2362.2001.00809.x. Eur J Clin Invest. 2001. PMID: 11454016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters